¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"serum response factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
carcinogenic factor
¹ß¾ÏÀÎÀÚ
corticotropin-releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
chemotactic factor
ÈÇнò¸²ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dilution factor
Èñ¼®ÀÎÀÚ
exclusion of confounding factor
±³¶õ¹èÁ¦ÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇÇÀ¯·¡¼öÃàÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
carcinogenic factor
¹ß¾ÏÀÎÀÚ
chemotactic factor
ÈÇÐÁÖ¼ºÀÎÀÚ, ÈÇнò¸²ÀÎÀÚ
coagulation factor
ÀÀ°íÀÎÀÚ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
Àû°ÝÀÎÀÚ
competence inducing factor
Àû°ÝÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
Macrophage colony-stimulating factor
´ë½Ä¼¼Æ÷Áý¶ôÇü¼ºÃËÁøÀÎÀÚ(ÓÞãÝá¬øàó¢Õªû¡à÷õµòäì×í)à÷õµòäì×?
NGF=>nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
PAF =platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
PAF= platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
Q factor
Å¥ ÀÎÀÚ
Q-factor
Å¥-ÀÎÀÚ (ì×í)
R factor
³»¼ºÀÎÀÚ.
R factor
³»¼ºÀÎÀÚ.
Rh factor
RhÀÎÀÚ.
Stuart-Prower factor
½ºÆ©¾îÆ®-ÇÁ¶ó¿ö ÀÎÀÚ
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell replacing factor
T¼¼Æ÷ ´ëüÀÎÀÚ
T-cell growth factor
T-¼¼Æ÷¼ºÀåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
attachment response
¾ÖÂø¹ÝÀÀ
attention response
ÁÖÀÇ·Â ¹ÝÀÀ
audiometry, brainstem evoked response =BERA
³ú°£À¯¹ß¹ÝÀÀ û·Â°Ë»ç
audiometry, evoked response
À¯¹ß¹ÝÀÀû·Â°Ë»ç
audiometry, galvanic skin response =GSR-a.
ÇǺÎÀü±â¹ÝÀÀ û·Â°Ë»ç
audiometry, startle response
°æ¾Ç¹ÝÀÀû·Â°Ë»ç
autoimmune response
ÀÚ°¡¸é¿ª(í»Ê«Øóæµ) ¹ÝÀÀ(Úãëë)
autoimmune response
ÀÚ°¡¸é¿ª¹ÝÀÀ
avoidance reaction =a. response
ȸÇǹÝÀÀ(üÞùÚãëë)
biologic response modifier, BRM
»ýü¹ÝÀÀÁ¶Àý¹°Áú
biologic response modifiers
»ý¹°ÇÐÀû ¹ÝÀÀÁ¶ÀýÁ¦
biological response modifier (BRM)
»ý¹°ÇÐÀû¹ÝÀÀÁ¶Àý¹°Áú (BRM)
brainstem evoked response =BER
³ú°£À¯¹ß¹ÝÀÀ
brainstem evoked response audiometry =BERA
³ú°£À¯¹ß¹ÝÀÀ û·Â°Ë»ç
bulbocavernous evoked-response test
±¸Çظéü À¯¹ß¹ÝÀÀ°Ë»ç
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½